| | 1616761-01-3 Basic information More.. |
| Product Name: | methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate | | Synonyms: | methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate;Tofacitinib-28;Tofacitinib impurity 22/methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate;1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, methyl ester, (3R,4R);Azilsartan medoxomil impurity329;methyl 3-(4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate;Tofatinib Impurity 26;Tofacitinib Impurity 29 （scifinder） | | CAS: | 1616761-01-3 | | MF: | C17H23N5O3 | | MW: | 345.4 | | EINECS: | | | Mol File: | 1616761-01-3.mol |  |
|
|
1616761-01-3
Recommend Suppliers |
|